Access cutting-edge hidradenitis suppurativa (hs) treatment through this phase 2 clinical trial at a research site in Bowling Green. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Bowling Green location
Preparing your pre-screening questions…
Access hidradenitis suppurativa (hs) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hidradenitis suppurativa (hs) treatment provided free
Check if you qualify for this hidradenitis suppurativa (hs) clinical trial in Bowling Green, KY
No-Cost Study Care
Local to Bowling Green
Convenient for KY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This Phase 2 study will test whether the investigational medicine, SPY072, improves hidradenitis suppurativa (HS) in adults with moderate to severe disease receiving advanced standard of care treatment. About 150 participants will be assigned by chance to receive either SPY072 or placebo for 16 weeks. Participants will be followed after the treatment period to evaluate safety and how long treatment effects may last.
Sponsor: Spyre Therapeutics, Inc.
Yes, this clinical trial (NCT07766005) has an active research site in Bowling Green, KY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hidradenitis suppurativa (hs) treatment options in Bowling Green, KY, this clinical trial (NCT07766005) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Bowling Green research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced hidradenitis suppurativa (hs) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hidradenitis suppurativa (hs) clinical trials near you to find additional studies recruiting in your area.
See all alzheimers disease clinical trials recruiting in Bowling Green — not just this study.
Browse Alzheimers Disease Trials in Bowling Green →